Form 4: Sera Prognostics Chief Scientific Officer Sells Shares for Tax Obligations

Sera Prognostics' Chief Scientific Officer, John J. Boniface, sold 1,439 shares of Class A Common Stock at a weighted average price of $1.48 to satisfy tax withholding obligations related to restricted stock unit vesting.

Summary

• John J. Boniface, the Chief Scientific Officer of Sera Prognostics, Inc. (SERA), reported a transaction on June 10, 2025.
• He disposed of 1,439 shares of Sera Prognostics Class A Common Stock.
• The shares were sold at a weighted average price of $1.48 per share, with individual transaction prices ranging from $1.45 to $1.51.
• The sale was explicitly stated as a 'sell to cover' transaction, mandated by the issuer, to satisfy tax withholding obligations in connection with the vesting of restricted stock units (RSUs).
• This transaction does not represent a discretionary sale by Mr. Boniface.
• Following this reported transaction, Mr. Boniface beneficially owns 167,982 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine 'sell to cover' for tax obligations related to RSU vesting, not a discretionary sale, thus it has a neutral sentiment as it does not reflect management's view on the company's future prospects.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs), which typically implies the achievement of certain performance milestones or tenure by the Chief Scientific Officer.

Negatives

• The sale of shares, while non-discretionary, reduces the direct ownership stake of a key executive in the company.

Future Outlook

NA

Management Comments

• The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by 'sell to cover' transactions and does not represent a discretionary transaction by the Reporting Person.

Industry Context

This Form 4 filing is specific to Sera Prognostics and details an insider transaction, which does not directly relate to broader industry trends or competitors.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine administrative transaction for tax purposes, not a discretionary sale indicating a change in insider sentiment or a shift in the company's strategic direction.

Key Dates

Recommendation

Keywords

SEC Form 4, Sera Prognostics, SERA, insider trading, stock sale, restricted stock units, RSU vesting, tax withholding, John J. Boniface, Chief Scientific Officer